Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo
NonSegmental Vitiligo · Nonsegmental Vitiligo (Stable)
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 60 Estimated
- Expected completion
- Feb 17, 2028
- Record updated
- Feb 27, 2026
- Lead sponsor
- Hudson Biotech